Becton Dickinson
About: Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Employees: 74,000
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
278% more call options, than puts
Call options by funds: $792M | Put options by funds: $209M
25% more funds holding in top 10
Funds holding in top 10: 20 [Q4 2024] → 25 (+5) [Q1 2025]
3% more first-time investments, than exits
New positions opened: 135 | Existing positions closed: 131
2% less repeat investments, than reductions
Existing positions increased: 595 | Existing positions reduced: 606
3% less capital invested
Capital invested by funds: $60.5B [Q4 2024] → $58.5B (-$2B) [Q1 2025]
1.0% less ownership
Funds ownership: 89.86% [Q4 2024] → 88.86% (-1.0%) [Q1 2025]
1% less funds holding
Funds holding: 1,597 [Q4 2024] → 1,575 (-22) [Q1 2025]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$185
5%
upside
Avg. target
$206
17%
upside
High target
$241
37%
upside
5 analyst ratings
3 positive
60%
2 neutral
40%
0 negative
0%
Barclays Matt Miksic | 37%upside $241 | Overweight Maintained | 3 Jun 2025 |
Citigroup Joanna Wiensch | 5%upside $185 | Neutral Downgraded | 22 May 2025 |
Morgan Stanley Patrick Wood | 11%upside $196 | Overweight Maintained | 6 May 2025 |
Piper Sandler Jason Bednar | 5%upside $185 | Neutral Downgraded | 2 May 2025 |
Stifel Rick Wise | 27%upside $224 | Buy Maintained | 2 May 2025 |
Financial journalist opinion
Based on 6 articles about BDX published over the past 30 days
Neutral
PRNewsWire
4 days ago
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strategy.
Positive
24/7 Wall Street
1 week ago
3 Undervalued Dividend King Stocks With Over 50% Upside Potential
As we enter the second half of 2025, now is the perfect time to invest in dividend stocks — especially those with quality underlying fundamentals that pay high dividend yields.
Positive
Seeking Alpha
1 week ago
Best Dividend Aristocrats For July 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising payouts in 2025 and an average growth rate of 4.86%. I identified 21 Aristocrats as both potentially undervalued and offering a projected long-term annualized return of at least 10%.
Neutral
CNBC Television
2 weeks ago
New vaccine panel meeting underway
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on vaccines.
Negative
Benzinga
2 weeks ago
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now
Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until early June 2027. Here's a breakdown of why the stock's structure looks weak under the lens of the Adhishthana Principles, our proprietary cyclical framework combining behavioral archetypes, timing structures, and quantitative signals.
Positive
Seeking Alpha
2 weeks ago
Best Dividend Kings: June 2025
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a collective 2025 growth rate of 5.19%, despite some downward earnings revisions. Seventeen Dividend Kings appear undervalued and offer long-term annualized expected returns of at least 10%, based on Dividend Yield Theory analysis.
Neutral
Seeking Alpha
1 month ago
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
Becton, Dickinson and Company (NYSE:BDX ) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Call Participants Robert Justin Marcus - JPMorgan Chase & Co, Research Division Unidentified Analyst Yes.
Positive
Seeking Alpha
1 month ago
Becton, Dickinson: A Dividend King Facing Challenges Offers Value
Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent dividend safety, and a conservative payout ratio, making it a reliable Dividend King. Despite tariff headwinds, competition, and restructuring risks, BDX's innovation, acquisitions, and organic growth support long-term revenue and EPS expansion.
Positive
Seeking Alpha
1 month ago
June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term earnings growth potential could justify current prices. These five dividend aristocrats, currently trading at a 42% historical discount, offer exceptional return potential and a significant margin of safety.
Positive
Seeking Alpha
1 month ago
June's Dividend Kings: 3 Ideal Buys In 25 "Safer" Dogs
Most Dividend Kings are currently overpriced, but six offer fair value where annual dividends from $1,000 invested exceed their share price. Three top-yield Dividend Kings—Altria, Northwest Natural, and Canadian Utilities—meet the ideal 'dogcatcher' standard for fair pricing and dividend safety. Analyst projections suggest select Dividend Kings could deliver up to 58% total returns by June 2026, with lower volatility than the market overall.
Charts implemented using Lightweight Charts™